CClinicalTrials.gg
CompletedNCT00681200HMECUpdated Apr 14, 2022

Evaluating Mechanisms of Blood Pressure Reduction Using Meditation in Hypertensive African Americans

An interventional study of Enhanced health education and Transcendental Meditation program in Hypertension, sponsored by Maharishi International University. Completed at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2022-04-14.

Sponsored by Maharishi International University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
152
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

High blood pressure is a common health problem among people in the United States. This study will compare the effectiveness of a meditation program versus a health education program at decreasing stress and lowering blood pressure levels among African-American adults with high blood pressure.

Read the detailed description

Hypertension, also known as high blood pressure, is one of the most common health problems among adults, particularly African Americans. If left untreated, it can lead to heart failure, kidney failure, or stroke. High blood pressure can be caused by many factors, including stress, diet, diabetes, kidney disease, or obesity. Typical treatments include taking medication, losing weight, and quitting smoking. Meditation may also be an effective way to decrease stress levels and lower blood pressure. This study will examine the effects of a specific type of meditation, Transcendental Meditation (TM), on stress and blood pressure levels. In previous studies, TM has been shown to have a positive effect on reducing blood pressure levels, but more research is needed to confirm these benefits. This study will compare the effectiveness of a TM program with an enhanced health education (EHE) program for reducing stress and blood pressure levels in African Americans with high blood pressure.

This 4-month study will enroll African Americans with early stage hypertension. Recruiting will be conducted from Howard University Medical Center in Washington, DC. First, participants will take part in 3 days of baseline testing, including a medical history review, blood pressure and heart rate measurements, an echocardiogram to obtain images of the heart, and blood and urine collection. Over a 24-hour period, blood pressure and heart rate will be measured continuously and participants will wear a pedometer to keep track of the distance they walk. Participants will also complete a stress test; a treadmill exercise test; and questionnaires on mental health, physical health, and lifestyle.

After the 3-day baseline period, participants will attend an informational meeting with the study staff and other study participants. They will then be randomly assigned to either the TM group or the EHE group. Participants in the TM group will learn a simple meditation technique over a 6-day period. They will be expected to meditate for 20 minutes twice a day for 4 months. Participants will attend follow-up meetings with a meditation instructor every 2 weeks throughout the study, and they will record their progress in a daily diary. Participants in the EHE program will take part in 14 events during the study, including watching educational films, listening to guest speakers, and participating in other instructional activities that will provide health information about blood pressure regulation. In addition, all participants will attend standard health education classes every 2 weeks. These classes will provide information about reducing the risk factors related to heart disease and stroke. Once a month, participants will attend a study visit and undergo blood pressure and heart rate measurements. At the end of the 4-month study period, all participants will undergo repeat baseline testing.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • Blood Pressure Reduction
  • Stress Reactivity and Recovery
  • Meditation
  • Transcendental Meditation
  • Stress Reduction
  • Stress Management
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 152 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

Maharishi International University is the lead sponsor of 16 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Self-identifies as African American
  • Resides in Washington, DC or surrounding communities
  • Has stage I hypertension, defined as systolic blood pressure between 140 and 159 mm Hg and/or diastolic blood pressure between 90 and 99 mm Hg, on average, without taking antihypertensive medications in the sympatholytic class (e.g., beta blockers, alpha antagonists, central nervous system agonists)

Exclusion criteria

Exclusion Criteria:

  • Blood pressure levels of less than 140/90 mm Hg or greater than 160/100 mm Hg
  • History of clinical cardiovascular disease (e.g., heart attack, angina, intermittent claudication, congestive heart failure, stroke)
  • Long-term kidney failure
  • Any other life-threatening illness (e.g., advanced cancer)
  • History of major psychiatric disorder (e.g., psychosis, dementia, substance abuse disorder)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
152 participants (actual)

Study arms

  • Active comparator
    Enhanced health education program

    This active treatment group consists of classes in health education and a social support group to enhance participant motivation and positive reinforcement to make healthier lifestyle choices (e.g. wholesome diet, increased exercise, reduced salt intake, and decreased use of alcohol and smoking). Note that this comparison group does not have a stress management component.

    Behavioral: Enhanced health education

  • Experimental
    Transcendental Meditation program

    Transcendental Meditation program plus health education. Basic American Heart Association (AHA) recommendations for lifestyle modification to reduce risk of heart disease will be given in a didactic classroom context.

    Behavioral: Transcendental Meditation program

Interventions

  • BehavioralEnhanced health education

    health education and social support

  • BehavioralTranscendental Meditation program

    The TM program plus didactic-based health education classes

06

What researchers measure

Primary outcomes

  1. In-clinic and ambulatory blood pressure

    Time frame: Measured at Month 4

Secondary outcomes

  1. Cardiovascular hemodynamics and stress hormones

    Time frame: Measured at Month 4

  2. telomerase gene expression

    telomerase gene expression as measured HTERT and HTR

    Time frame: 4 months

07

Study locations

1 site
  • Howard University College of Medicine
    Washington, District of Columbia 20060, United States
08

References and documents

Publications

  • Duraimani SLC (2012) Lifestyle Modifications and Healthy Biological Aging: Effects of Telomerase Activity and Telomere Length. Ann Arbor Mich: Dissertation Information Service
  • Duraimani S, Schneider RH, Randall OS, Nidich SI, Xu S, Ketete M, Rainforth MA, Gaylord-King C, Salerno JW, Fagan J. Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans. PLoS One. 2015 Nov 16;10(11):e0142689. doi: 10.1371/journal.pone.0142689. eCollection 2015. PubMed 26571023 ↗

Individual participant data

Plan to share: Yes — outside investigators may contact the study PIs for sharing of the database

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00681200
Lead sponsor
Maharishi International University
Collaborators
Howard University, National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Robert Schneider, MD (Director, Center for Natural Medicine and Prevention, Maharishi International University) — Principal investigator
First posted
May 21, 2008
Start date
Apr 2008
Primary completion
Jul 2011
Completion
May 2012
Last update
Apr 14, 2022

Study contacts

Otelio Randall, MD
principal investigator · Howard University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion